BACKGROUND: Offspring of women with gestational diabetes (OGD) have greater risk for obesity and impaired metabolic health. Whether impaired metabolic health occurs in the absence of obesity is not clear. OBJECTIVE: The purpose of this study was to investigate the independent and interactive effects of intrauterine exposure to gestational diabetes and of children's current weight status on their metabolic health. METHODS: Children aged 5–10 years (n = 51) with and without intrauterine exposure to gestational diabetes (OGD vs. offspring of non-diabetic women [CTRL]) were grouped into normal weight (body mass index [BMI] < 85th %) and overweight (BMI > 85th %) according to Centers for Disease Control growth curves. Lipid profile was obtained by fasting blood draw, insulin sensitivity (SI) and secretion by liquid meal tolerance test, and body composition by dual-energy X-ray absorptiometry. RESULTS: Despite similar average BMI percentiles among normal weight OGD versus CTRL, and overweight OGD vs. CTRL, OGD had greater total %fat and trunk fat adjusted for leg fat compared with CTRL (P < 0.05). Overweight children had lower SI (P < 0.05) and greater basal, static, and total insulin secretion independent of SI (P < 0.05). OGD was independently associated with greater static insulin secretion (P < 0.05) and the interaction between OGD and overweight was associated with greater basal insulin secretion independent of SI (P < 0.01). OGD and overweight were each associated with lower high-density lipoprotein-cholesterol (HDL-C) (P < 0.05). CONCLUSION: Intrauterine exposure to gestational diabetes was associated with greater central adiposity and insulin secretion, and lower HDL-C, irrespective of current weight status. Future research should examine respective contributions of the intrauterine environment and of underlying genotype on children's metabolic health.
BACKGROUND: Offspring of women with gestational diabetes (OGD) have greater risk for obesity and impaired metabolic health. Whether impaired metabolic health occurs in the absence of obesity is not clear. OBJECTIVE: The purpose of this study was to investigate the independent and interactive effects of intrauterine exposure to gestational diabetes and of children's current weight status on their metabolic health. METHODS:Children aged 5–10 years (n = 51) with and without intrauterine exposure to gestational diabetes (OGD vs. offspring of non-diabeticwomen [CTRL]) were grouped into normal weight (body mass index [BMI] < 85th %) and overweight (BMI > 85th %) according to Centers for Disease Control growth curves. Lipid profile was obtained by fasting blood draw, insulin sensitivity (SI) and secretion by liquid meal tolerance test, and body composition by dual-energy X-ray absorptiometry. RESULTS: Despite similar average BMI percentiles among normal weight OGD versus CTRL, and overweight OGD vs. CTRL, OGD had greater total %fat and trunk fat adjusted for leg fat compared with CTRL (P < 0.05). Overweight children had lower SI (P < 0.05) and greater basal, static, and total insulin secretion independent of SI (P < 0.05). OGD was independently associated with greater static insulin secretion (P < 0.05) and the interaction between OGD and overweight was associated with greater basal insulin secretion independent of SI (P < 0.01). OGD and overweight were each associated with lower high-density lipoprotein-cholesterol (HDL-C) (P < 0.05). CONCLUSION:Intrauterine exposure to gestational diabetes was associated with greater central adiposity and insulin secretion, and lower HDL-C, irrespective of current weight status. Future research should examine respective contributions of the intrauterine environment and of underlying genotype on children's metabolic health.
Authors: Saul Genuth; K G M M Alberti; Peter Bennett; John Buse; Ralph Defronzo; Richard Kahn; John Kitzmiller; William C Knowler; Harold Lebovitz; Ake Lernmark; David Nathan; Jerry Palmer; Robert Rizza; Christopher Saudek; Jonathan Shaw; Michael Steffes; Michael Stern; Jaako Tuomilehto; Paul Zimmet Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112
Authors: Nikki C Bush; Paula C Chandler-Laney; Dwight J Rouse; Wesley M Granger; Robert A Oster; Barbara A Gower Journal: J Clin Endocrinol Metab Date: 2011-02-23 Impact factor: 5.958
Authors: Matthew W Gillman; Sheryl Rifas-Shiman; Catherine S Berkey; Alison E Field; Graham A Colditz Journal: Pediatrics Date: 2003-03 Impact factor: 7.124
Authors: Louise G Grunnet; Susanne Hansen; Line Hjort; Camilla M Madsen; Freja B Kampmann; Anne Cathrine B Thuesen; Charlotta Granstrømi; Marin Strøm; Ekaterina Maslova; Ruth Frikke-Schmidt; Peter Damm; Jorge E Chavarro; Frank B Hu; Sjurdur F Olsen; Allan Vaag Journal: Diabetes Care Date: 2017-10-16 Impact factor: 19.112
Authors: Jasmin M Alves; Jennifer Zink; Ting Chow; Shan Luo; Britni R Belcher; Anny H Xiang; Kathleen A Page Journal: J Clin Endocrinol Metab Date: 2020-07-01 Impact factor: 5.958
Authors: Emily K Blue; Kimberly Ballman; Frances Boyle; Eunjin Oh; Tatsuyoshi Kono; Sara K Quinney; Debbie C Thurmond; Carmella Evans-Molina; Laura S Haneline Journal: Pediatr Res Date: 2014-11-20 Impact factor: 3.756